Literature DB >> 18274554

Viral pro-survival proteins block separate stages in Bax activation but changes in mitochondrial ultrastructure still occur.

J R Cross1, A Postigo, K Blight, J Downward.   

Abstract

Mitochondrial dysfunction mediated by Bax and Bak is a critical step in mammalian cell apoptosis. However, the molecular mechanism of Bax activation remains unknown and has been difficult to investigate due to its rapid and stochastic nature. It is currently unclear whether mitochondria play a passive role in the initiation of apoptosis, remaining unaffected by cell stresses until Bax and Bak are active, or whether they actively participate in Bax/Bak activation. Here, two viral proteins, E1B19K and BHRF1, are examined for their ability to block Bax activation at different steps and thereby reveal the timing of mitochondrial changes during apoptosis. We demonstrate that BHRF1 strongly inhibits Bax activation but not upstream apoptotic signaling events, while E1B19K permits initial stages of Bax activation but prevents the subsequent oligomerization of Bax that is required for mitochondrial dysfunction. In this defined system we show that changes in mitochondrial ultrastructure, characteristic of cells undergoing apoptosis, precede Bax activation and are not blocked by E1B19K and BHRF1. We suggest that the ability of mitochondria to respond to apoptotic stress prior to Bax activation indicates that these organelles may play a direct role in activating Bax.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18274554     DOI: 10.1038/cdd.2008.14

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  13 in total

Review 1.  Therapeutic modulation of apoptosis: targeting the BCL-2 family at the interface of the mitochondrial membrane.

Authors:  Kathleen N Nemec; Annette R Khaled
Journal:  Yonsei Med J       Date:  2008-10-31       Impact factor: 2.759

2.  Oncolytic adenoviral mutants with E1B19K gene deletions enhance gemcitabine-induced apoptosis in pancreatic carcinoma cells and anti-tumor efficacy in vivo.

Authors:  Stephan Leitner; Katrina Sweeney; Daniel Oberg; Derek Davies; Enrique Miranda; Nick R Lemoine; Gunnel Halldén
Journal:  Clin Cancer Res       Date:  2009-02-17       Impact factor: 12.531

3.  Dissecting the roles of E1A and E1B in adenoviral replication and RCAd-enhanced RDAd transduction efficacy on tumor cells.

Authors:  Fang Wei; Huiping Wang; Xiafang Chen; Chuanyuan Li; Qian Huang
Journal:  Cancer Biol Ther       Date:  2014-07-14       Impact factor: 4.742

4.  Improved potency and selectivity of an oncolytic E1ACR2 and E1B19K deleted adenoviral mutant in prostate and pancreatic cancers.

Authors:  Daniel Oberg; Eva Yanover; Virginie Adam; Katrina Sweeney; Celina Costas; Nick R Lemoine; Gunnel Halldén
Journal:  Clin Cancer Res       Date:  2010-01-12       Impact factor: 12.531

Review 5.  Epstein-Barr virus interactions with the Bcl-2 protein family and apoptosis in human tumor cells.

Authors:  Qin Fu; Chen He; Zheng-rong Mao
Journal:  J Zhejiang Univ Sci B       Date:  2013-01       Impact factor: 3.066

6.  Praf2 is a novel Bcl-xL/Bcl-2 interacting protein with the ability to modulate survival of cancer cells.

Authors:  Maria Teresa Vento; Valeria Zazzu; Alessia Loffreda; Justin R Cross; Julian Downward; Maria Patrizia Stoppelli; Ingram Iaccarino
Journal:  PLoS One       Date:  2010-12-20       Impact factor: 3.240

7.  Structural basis for apoptosis inhibition by Epstein-Barr virus BHRF1.

Authors:  Marc Kvansakul; Andrew H Wei; Jamie I Fletcher; Simon N Willis; Lin Chen; Andrew W Roberts; David C S Huang; Peter M Colman
Journal:  PLoS Pathog       Date:  2010-12-23       Impact factor: 6.823

Review 8.  How does Epstein-Barr virus (EBV) complement the activation of Myc in the pathogenesis of Burkitt's lymphoma?

Authors:  Martin J Allday
Journal:  Semin Cancer Biol       Date:  2009-07-25       Impact factor: 15.707

Review 9.  Mitochondrial Proteins Coded by Human Tumor Viruses.

Authors:  Ilaria Cavallari; Gloria Scattolin; Micol Silic-Benussi; Vittoria Raimondi; Donna M D'Agostino; Vincenzo Ciminale
Journal:  Front Microbiol       Date:  2018-02-06       Impact factor: 5.640

10.  The E1B19K-deleted oncolytic adenovirus mutant AdΔ19K sensitizes pancreatic cancer cells to drug-induced DNA-damage by down-regulating Claspin and Mre11.

Authors:  Constantia Pantelidou; Gioia Cherubini; Nick R Lemoine; Gunnel Halldén
Journal:  Oncotarget       Date:  2016-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.